Supraphysiological doses of GH induce rapid changes in cardiac morphology and function

The Journal of Clinical Endocrinology and Metabolism
Antonio CittadiniLuigi Saccà

Abstract

GH is an agent widely used in sport to improve physical performance and has been proposed as adjunctive therapy in several clinical conditions. However, its short-term effects on the normal human heart are poorly understood. Sixty young normal volunteers (30 males and 30 females) were enrolled in a multicenter, double-blind, placebo-controlled study. All subjects were randomized to receive GH (0.03 or 0.06 mg/kg.d) or placebo. A complete Doppler-echocardiographic examination was performed at baseline and after 4 wk of treatment. Low-dose GH did not significantly affect echocardiographic parameters. In contrast, high-dose GH increased left ventricular mass index by 12% (P < 0.05). The type of growth response was concentric, because left ventricular wall thickness but not diameter increased, leading to a 10% increase of relative wall thickness. These structural changes were associated with functional changes, including a significant increase in cardiac index and a decrease in peripheral vascular resistance; diastolic function was not altered. Fractional shortening and systemic blood pressure were unchanged in the two treatment groups. In conclusion, administration of GH for 4 wk at doses that simulate GH abuse in sport caused a h...Continue Reading

References

Dec 1, 1992·Clinical Pediatrics·V I RickertM S Jay
Aug 1, 1991·International Journal of Sports Medicine·B De PiccoliE Piccolo
Dec 1, 1986·The Journal of Clinical Investigation·R C Baxter, J L Martin
Jul 1, 1986·Annals of Clinical Biochemistry·J D Teale, V Marks
Dec 1, 1969·The American Journal of Physiology·A HjalmarsonK Ahrén
Oct 1, 1994·Endocrine Reviews·L SaccàS Fazio
Mar 1, 1994·Clinical Endocrinology·K CaidahlB A Bengtsson
Mar 28, 1996·The New England Journal of Medicine·S FazioL Saccà
Jun 17, 1998·The Journal of Clinical Endocrinology and Metabolism·Y B SverrisdóttirG Johannsson
Jun 17, 1998·Journal of the American College of Cardiology·J K GhaliR S Cooper
Nov 4, 1998·Lancet·K Birchard
Nov 11, 1998·Journal of the American College of Cardiology·A W HaiderD Levy
Sep 1, 1999·Clinical Endocrinology·P J Jenkins
Jan 14, 2000·The Journal of Clinical Endocrinology and Metabolism·S FazioL Saccà
Jan 21, 2000·Journal of Applied Physiology·G Gayan-RamirezM Decramer
Sep 16, 2000·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·R H Böger
Sep 22, 2000·The Journal of Clinical Endocrinology and Metabolism·B CapaldoL Saccà
Jan 12, 2001·Journal of the American College of Cardiology·M A SaderD S Celermajer
Mar 7, 2001·American Heart Journal·B A VakiliR B Devereux
Apr 17, 2001·The Journal of Biological Chemistry·C LuR K Menon

❮ Previous
Next ❯

Citations

Apr 29, 2010·Circulation. Heart Failure·Aaron L BaggishHarrison G Pope
Mar 23, 2011·Trends in Endocrinology and Metabolism : TEM·Vita BirznieceKen K Y Ho
Feb 4, 2010·Endocrinology and Metabolism Clinics of North America·Vita BirznieceKen K Y Ho
Aug 1, 2009·Journal of Cardiac Failure·Christoph Ahlgrim, Maya Guglin
Aug 29, 2007·Pediatric Clinics of North America·Sergio R R Buzzini
May 23, 2007·The Journal of Pediatrics·Lea Ann MaturaCarolyn A Bondy
Dec 24, 2010·The American Journal on Addictions·Brian P BrennanHarrison G Pope
Nov 6, 2014·Internal Medicine Journal·Vita Birzniece
Oct 26, 2016·International Journal of Cardiology·Andrea SalzanoUNKNOWN T.O.S.CA. investigators
Feb 16, 2017·The Journal of Clinical Endocrinology and Metabolism·Pierre ChatelainUNKNOWN TransCon GH Working Group
Feb 21, 2004·Clinical Endocrinology·Luigi SaccàAntonio Cittadini
Mar 30, 2013·The Journal of Clinical Endocrinology and Metabolism·Shlomo Melmed
Apr 24, 2008·The Journal of Clinical Endocrinology and Metabolism·Jochem van den BergWillem A Helbing
Mar 2, 2006·The Journal of Clinical Endocrinology and Metabolism·Carolyn A BondyVincent B Ho
Jun 27, 2019·The New England Journal of Medicine·Shlomo Melmed
Nov 27, 2016·International Journal of Clinical Pharmacy·Róbert György VidaLajos Botz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.